When the FDA Comes A Knockin’

Previously in posts Hello From Greyledge and Is There a Way to Refine the Practice of Regenerative Medicine?(opens in a new tab), I introduced Greyledge Technologies and the service it provides to physicians and surgeons who have decided to use platelet rich plasma (PRP) and bone marrow concentrated cells (BMCC) either as adjunctive therapy during a surgical procedure [...]